Patents Assigned to PhotoMedex
  • Patent number: 8746253
    Abstract: Skin disorders such as, for example, atopic dermatitis, dyshidrosis, eczema, lichen planus, psoriasis, and vitiligo, are treated by applying high doses of ultraviolet light to diseased regions of a patient's skin. The dosage exceeds 1 MED as determined for the particular patient and may range from about 1 MED to about 20 MED or higher. The ultraviolet light has a wavelength within the range of about 295 nanometers to about 320 nanometers. High doses of ultraviolet light are preferably restricted to diseased tissue areas. A specialized handpiece provides a beam profile especially suitable for application of controlled doses. A specialized delivery device is useful for UV treatment of tissue within the mouth.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: June 10, 2014
    Assignee: Photomedex
    Inventor: Dean S. Irwin
  • Patent number: 8486056
    Abstract: Skin disorders such as, for example, atopic dermatitis, dyshidrosis, eczema, lichen planus, psoriasis, and vitiligo, are treated by applying high doses of ultraviolet light to diseased regions of a patients skin. The dosage employed exceeds 1 MED, an MED being determined for the particular patient being treated, and may range from about 1 MED to about 20 MED or higher. The ultraviolet light has a wavelength within the range of between about 295 nanometers to about 320 nanometers and preferably is between about 300 nanometers and about 310 nanometers. High doses of ultraviolet light are restricted to diseased tissue areas so as to avoid risk of detrimental side affects in healthy skin, which is more susceptible to damage from UV light. Cooling the skin prior to and/or while exposing the skin to the UV light can be used to minimize tissue damage resulting from exposure to the UV light. Higher doses of UV light can therefore be employed without injurious affects.
    Type: Grant
    Filed: March 3, 2010
    Date of Patent: July 16, 2013
    Assignee: Photomedex
    Inventor: Dean S. Irwin
  • Patent number: 8454669
    Abstract: Skin disorders such as, for example, atopic dermatitis, dyshidrosis, eczema, lichen planus, psoriasis, and vitiligo, are treated by applying high doses of ultraviolet light to diseased regions of a patient's skin. The dosage exceeds 1 MED as determined for the particular patient and may range from about 1 MED to about 20 MED or higher. The ultraviolet light has a wavelength within the range of about 295 nanometers to about 320 nanometers. High doses of ultraviolet light are preferably restricted to diseased tissue areas. A specialized handpiece provides a beam profile especially suitable for application of controlled doses. A specialized delivery device is useful for UV treatment of tissue within the mouth.
    Type: Grant
    Filed: February 18, 2011
    Date of Patent: June 4, 2013
    Assignee: Photomedex
    Inventor: Dean S. Irwin
  • Publication number: 20130018442
    Abstract: Skin disorders such as, for example, atopic dermatitis, dyshidrosis, eczema, lichen planus, psoriasis, and vitiligo, are treated by applying high doses of ultraviolet light to diseased regions of a patient's skin. The dosage exceeds 1 MED as determined for the particular patient and may range from about 1 MED to about 20 MED or higher. The ultraviolet light has a wavelength within the range of about 295 nanometers to about 320 nanometers. High doses of ultraviolet light are preferably restricted to diseased tissue areas. A specialized handpiece provides a beam profile especially suitable for application of controlled doses. A specialized delivery device is useful for UV treatment of tissue within the mouth.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 17, 2013
    Applicant: PhotoMedex
    Inventors: Dean S. Irwin, Dennis McGrath
  • Publication number: 20130013032
    Abstract: Skin disorders such as, for example, atopic dermatitis, dyshidrosis, eczema, lichen planus, psoriasis, and vitiligo, are treated by applying high doses of ultraviolet light to diseased regions of a patients skin. The dosage employed exceeds 1 MED, an MED being determined for the particular patient being treated, and may range from about 1 MED to about 20 MED or higher. The ultraviolet light has a wavelength within the range of between about 295 nanometers to about 320 nanometers and preferably is between about 300 nanometers and about 310 nanometers. High doses of ultraviolet light are restricted to diseased tissue areas so as to avoid risk of detrimental side affects in healthy skin, which is more susceptible to damage from UV light. Cooling the skin prior to and/or while exposing the skin to the UV light can be used to minimize tissue damage resulting from exposure to the UV light. Higher doses of UV light can therefore be employed without injurious affects.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 10, 2013
    Applicant: PHOTOMEDEX
    Inventor: Dean S. Irwin
  • Publication number: 20120219030
    Abstract: A method of recharging an excimer laser Includes opening an outlet in a chamber containing spent laser gas at a first pressure, opening an inlet in the chamber, the inlet in communication with a laser gas container at a second pressure higher than the first pressure, and flowing fresh laser gas into the chamber and removing at least a portion of the spent laser gases from the chamber without using a vacuum pump.
    Type: Application
    Filed: November 1, 2011
    Publication date: August 30, 2012
    Applicant: PHOTOMEDEX
    Inventor: Jeffrey I. Levatter
  • Publication number: 20120217418
    Abstract: An optical apparatus for treating tissue including an ultraviolet excimer laser configured to output ultraviolet light, an optical line configured to receive said ultraviolet light into a first end and to output said ultraviolet light from a second end, a wavelength converting device configured to receive said ultraviolet light output from said optical line and to produce longer wavelength emissions, and a delivery device configured to direct said longer wavelength emission to said tissue.
    Type: Application
    Filed: October 20, 2011
    Publication date: August 30, 2012
    Applicant: PhotoMedex
    Inventors: Jeffrey I. Levatter, Michael R. Stewart
  • Publication number: 20110196457
    Abstract: Skin disorders such as, for example, atopic dermatitis, dyshidrosis, eczema, lichen planus, psoriasis, and vitiligo, are treated by applying high doses of ultraviolet light to diseased regions of a patient's skin. The dosage exceeds 1 MED as determined for the particular patient and may range from about 1 MED to about 20 MED or higher. The ultraviolet light has a wavelength within the range of about 295 nanometers to about 320 nanometers. High doses of ultraviolet light are preferably restricted to diseased tissue areas. A specialized handpiece provides a beam profile especially suitable for application of controlled doses. A specialized delivery device is useful for UV treatment of tissue within the mouth.
    Type: Application
    Filed: February 18, 2011
    Publication date: August 11, 2011
    Applicant: PhotoMedex
    Inventor: Dean S. Irwin
  • Patent number: 7891361
    Abstract: Skin disorders such as, for example, atopic dermatitis, dyshidrosis, eczema, lichen planus, psoriasis, and vitiligo, are treated by applying high doses of ultraviolet light to diseased regions of a patient's skin. The dosage exceeds 1 MED as determined for the particular patient and may range from about 1 MED to about 20 MED or higher. The ultraviolet light has a wavelength within the range of about 295 nanometers to about 320 nanometers. High doses of ultraviolet light are preferably restricted to diseased tissue areas. A specialized handpiece provides a beam profile especially suitable for application of controlled doses. A specialized delivery device is useful for UV treatment of tissue within the mouth.
    Type: Grant
    Filed: May 8, 2006
    Date of Patent: February 22, 2011
    Assignee: PhotoMedex
    Inventor: Dean S. Irwin
  • Patent number: 7886749
    Abstract: Skin disorders such as, for example, atopic dermatitis, dyshidrosis, eczema, lichen planus, psoriasis, and vitiligo, are treated by applying high doses of ultraviolet light to diseased regions of a patients skin. The dosage employed exceeds 1 MED, an MED being determined for the particular patient being treated, and may range from about 1 MED to about 20 MED or higher. The ultraviolet light has a wavelength within the range of between about 295 nanometers to about 320 nanometers and preferably is between about 300 nanometers and about 310 nanometers. High doses of ultraviolet light are restricted to diseased tissue areas so as to avoid risk of detrimental side affects in healthy skin, which is more susceptible to damage from UV light. Cooling the skin prior to and/or while exposing the skin to the UV light can be used to minimize tissue damage resulting from exposure to the UV light. Higher doses of TV light can therefore be employed without injurious affects.
    Type: Grant
    Filed: May 8, 2006
    Date of Patent: February 15, 2011
    Assignee: Photomedex
    Inventor: Dean S. Irwin
  • Publication number: 20110002918
    Abstract: Treatment protocols for severe psoriasis include administering biologics, stopping all administration of the biologics after the severity of the psoriasis has reduced and has reached an equilibrium, mildness and/or a tolerable state of remission, and administering UV phototherapy. The biologics may include, for example, the biologics found in Amevive®, Enbrel®, Humira®, Raptiva®, and Remicade® and/or alefacept, etanercept, adalimumab, efalizumab, infliximab, and ustekinumab. The UV phototherapy may be repeated, for example daily, weekly, monthly, yearly, to keep the psoriasis in a mild state or in a tolerable state of substantial remission. Parameters for administering UV phototherapy may be determined based on skin tone, Fitzpatrick skin phenotype, the severity of the psoriasis, the area of exposure, and/or the MED.
    Type: Application
    Filed: March 5, 2010
    Publication date: January 6, 2011
    Applicant: PHOTOMEDEX
    Inventor: Jeffrey I. Levatter
  • Publication number: 20110004280
    Abstract: Skin disorders such as, for example, atopic dermatitis, dyshidrosis, eczema, lichen planus, psoriasis, and vitiligo, are treated by applying high doses of ultraviolet light to diseased regions of a patients skin. The dosage employed exceeds 1 MED, an MED being determined for the particular patient being treated, and may range from about 1 MED to about 20 MED or higher. The ultraviolet light has a wavelength within the range of between about 295 nanometers to about 320 nanometers and preferably is between about 300 nanometers and about 310 nanometers. High doses of ultraviolet light are restricted to diseased tissue areas so as to avoid risk of detrimental side affects in healthy skin, which is more susceptible to damage from UV light. Cooling the skin prior to and/or while exposing the skin to the UV light can be used to minimize tissue damage resulting from exposure to the UV light. Higher doses of UV light can therefore be employed without injurious affects.
    Type: Application
    Filed: March 3, 2010
    Publication date: January 6, 2011
    Applicant: PHOTOMEDEX
    Inventor: Dean S. Irwin
  • Publication number: 20100232469
    Abstract: Systems and methods for efficiently operating a gas discharge excimer laser are disclosed. The excimer laser may include a chamber containing laser gases, first and second electrodes within the chamber, and a plurality of reflective elements defining an optical resonant cavity. The method may include setting the laser gases to a first pressure; after setting the gases to the first pressure, applying a first voltage to the electrodes, thereby propagating a laser beam in the optical resonant cavity; measuring energy of the beam; adjusting the first voltage until the energy of the beam is substantially equal to a target pulse energy; operating the laser for an amount of time; after the amount of time, measuring energy of the beam; and changing the pressure of the gases to a second pressure different from the first pressure.
    Type: Application
    Filed: November 17, 2009
    Publication date: September 16, 2010
    Applicant: PHOTOMEDEX
    Inventors: Jeffrey I. Levatter, James H. Morris, David M. Brooks
  • Publication number: 20100195692
    Abstract: A method of recharging an excimer laser Includes opening an outlet in a chamber containing spent laser gas at a first pressure, opening an inlet in the chamber, the inlet in communication with a laser gas container at a second pressure higher than the first pressure, and flowing fresh laser gas into the chamber and removing at least a portion of the spent laser gases from the chamber without using a vacuum pump.
    Type: Application
    Filed: October 5, 2009
    Publication date: August 5, 2010
    Applicant: PHOTOMEDEX
    Inventor: Jeffrey I. Levatter
  • Publication number: 20080288032
    Abstract: Skin disorders such as, for example, atopic dermatitis, dyshidrosis, eczema, lichen planus, psoriasis, and vitiligo, are treated by applying high doses of ultraviolet light to diseased regions of a patient's skin. The dosage exceeds 1 MED as determined for the particular patient and may range from about 1 MED to about 20 MED or higher. The ultraviolet light has a wavelength within the range of about 295 nanometers to about 320 nanometers. High doses of ultraviolet light are preferably restricted to diseased tissue areas. A specialized handpiece provides a beam profile especially suitable for application of controlled doses. A specialized delivery device is useful for UV treatment of tissue within the mouth.
    Type: Application
    Filed: May 8, 2006
    Publication date: November 20, 2008
    Applicant: PhotoMedex
    Inventor: Dean S. Irwin
  • Publication number: 20080240197
    Abstract: Systems and methods for efficiently operating a gas discharge excimer laser are disclosed. The excimer laser may include a chamber containing laser gases, first and second electrodes within the chamber, and a plurality of reflective elements defining an optical resonant cavity. The method may include setting the laser gases to a first pressure; after setting the gases to the first pressure, applying a first voltage to the electrodes, thereby propagating a laser beam in the optical resonant cavity; measuring energy of the beam; adjusting the first voltage until the energy of the beam is substantially equal to a target pulse energy; operating the laser for an amount of time; after the amount of time, measuring energy of the beam; and changing the pressure of the gases to a second pressure different from the first pressure.
    Type: Application
    Filed: March 26, 2008
    Publication date: October 2, 2008
    Applicant: PHOTOMEDEX
    Inventors: Jeffrey I. Levatter, James H. Morris, David M. Brooks
  • Publication number: 20070282402
    Abstract: Skin disorders such as, for example, atopic dermatitis, dyshidrosis, eczema, lichen planus, psoriasis, and vitiligo, are treated by applying high doses of ultraviolet light to diseased regions of a patients skin. The dosage employed exceeds 1 MED, an MED being determined for the particular patient being treated, and may range from about 1 MED to about 20 MED or higher. The ultraviolet light has a wavelength within the range of between about 295 nanometers to about 320 nanometers and preferably is between about 300 nanometers and about 310 nanometers. High doses of ultraviolet light are restricted to diseased tissue areas so as to avoid risk of detrimental side affects in healthy skin, which is more susceptible to damage from UV light. Cooling the skin prior to and/or while exposing the skin to the UV light can be used to minimize tissue damage resulting from exposure to the UV light. Higher doses of UV light can therefore be employed without injurious affects.
    Type: Application
    Filed: August 20, 2007
    Publication date: December 6, 2007
    Applicant: PHOTOMEDEX
    Inventor: Dean Irwin
  • Patent number: 7276059
    Abstract: Skin disorders such as, for example, atopic dermatitis, dyshidrosis, eczema, lichen planus, psoriasis, and vitiligo, are treated by applying high doses of ultraviolet light to diseased regions of a patient's skin. The dosage exceeds 1 MED, as determined for the particular patient and may range from about 1 MED to about 20 MED or higher. The ultraviolet light has a wavelength within the range of about 295 nanometers to about 320 nanometers. High doses of ultraviolet light are restricted to diseased tissue areas The skin can be cooled prior to and/or during exposure to UV light to minimize tissue damage resulting from exposure to the UV light. Higher doses of UV light can therefore be employed without injurious affects.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: October 2, 2007
    Assignee: Photomedex
    Inventor: Dean S. Irwin
  • Patent number: 7257144
    Abstract: An excimer laser comprises a gas chamber, electrodes for creating rare gas/halide molecules that disassociate and produce optical emission, and reflective surfaces that form an optical resonant cavity. The excimer laser further comprises flow control surfaces that define gas flow paths and that control the flow of gas within the chamber. Preferably such flow control surfaces direct the gases away from the laser optics. More preferably, the flow control surfaces shield the path of the laser beam, at least in the proximity of the laser optics, from contaminants in the gases. Less contaminants yields less contamination of the laser optics. As a result, the laser device becomes more reliable and useful over longer periods of time. In addition, the laser gases are preferably exposed only to compatible materials that react with the laser gases to produce stable reaction products having a low vapor pressure, so as to reduce contamination of the gases and the optics.
    Type: Grant
    Filed: February 11, 2004
    Date of Patent: August 14, 2007
    Assignee: PhotoMedex
    Inventor: Jeffrey I. Levatter